Advertisement
UK markets close in 6 hours 39 minutes

  • FTSE 100

    8,439.73
    +5.97 (+0.07%)
     

  • FTSE 250

    20,654.46
    +9.08 (+0.04%)
     

  • AIM

    790.22
    +0.35 (+0.04%)
     

  • GBP/EUR

    1.1619
    -0.0003 (-0.03%)
     

  • GBP/USD

    1.2528
    +0.0003 (+0.02%)
     

  • Bitcoin GBP

    50,144.58
    +1,456.28 (+2.99%)
     

  • CMC Crypto 200

    1,292.91
    +32.70 (+2.59%)
     

  • S&P 500

    5,222.68
    +94.89 (+1.85%)
     

  • DOW

    39,512.84
    +837.14 (+2.16%)
     

  • CRUDE OIL

    78.60
    +0.34 (+0.43%)
     

  • GOLD FUTURES

    2,349.20
    -25.80 (-1.09%)
     

  • NIKKEI 225

    38,179.46
    -49.65 (-0.13%)
     

  • HANG SENG

    19,115.06
    +151.38 (+0.80%)
     

  • DAX

    18,739.70
    -33.15 (-0.18%)
     

  • CAC 40

    8,213.44
    -5.70 (-0.07%)
     

Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024

Business Wire
·1-min read

ATLANTA, April 17, 2024--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024. Following the news release, the company will host a conference call the next day, Wednesday, May 1, 2024, at 9:00 am ET to discuss the results.

Participants may access the call by dialing 1-844-826-3035 or 1-412-317-5195, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until May 15, 2024. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 10188006. An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at mirion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415596281/en/

Contacts

For investor inquiries, please contact:

Jerry Estes
ir@mirion.com